These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

254 related items for PubMed ID: 27769564

  • 21. IL-12 drives IFN-gamma-dependent autoimmune kidney disease in MRL-Fas(lpr) mice.
    Schwarting A, Tesch G, Kinoshita K, Maron R, Weiner HL, Kelley VR.
    J Immunol; 1999 Dec 15; 163(12):6884-91. PubMed ID: 10586090
    [Abstract] [Full Text] [Related]

  • 22. Anti-inflammatory activities of Ganoderma lucidum (Lingzhi) and San-Miao-San supplements in MRL/lpr mice for the treatment of systemic lupus erythematosus.
    Cai Z, Wong CK, Dong J, Jiao D, Chu M, Leung PC, Lau CBS, Lau CP, Tam LS, Lam CWK.
    Chin Med; 2016 Dec 15; 11():23. PubMed ID: 27134645
    [Abstract] [Full Text] [Related]

  • 23. Inhibition of EZH2 Ameliorates Lupus-Like Disease in MRL/lpr Mice.
    Rohraff DM, He Y, Farkash EA, Schonfeld M, Tsou PS, Sawalha AH.
    Arthritis Rheumatol; 2019 Oct 15; 71(10):1681-1690. PubMed ID: 31106974
    [Abstract] [Full Text] [Related]

  • 24. Mesenchymal stem cells-derived extracellular vesicles ameliorate lupus nephritis by regulating T and B cell responses.
    Li C, Wu F, Mao J, Wang Y, Zhu J, Hong K, Xie H, Zhou X, Tian J, Wen C.
    Stem Cell Res Ther; 2024 Jul 18; 15(1):216. PubMed ID: 39020448
    [Abstract] [Full Text] [Related]

  • 25. Erythropoietin Treatment Ameliorates Lupus Nephritis of MRL/lpr Mice.
    Zhang Z, Liu D, Zhang X, Wang X.
    Inflammation; 2018 Oct 18; 41(5):1888-1899. PubMed ID: 29951872
    [Abstract] [Full Text] [Related]

  • 26. Tamoxifen alleviates disease severity and decreases double negative T cells in autoimmune MRL-lpr/lpr mice.
    Wu WM, Suen JL, Lin BF, Chiang BL.
    Immunology; 2000 May 18; 100(1):110-8. PubMed ID: 10809966
    [Abstract] [Full Text] [Related]

  • 27. Unique therapeutic effects of the Japanese-Chinese herbal medicine, Sairei-to, on Th1/Th2 cytokines balance of the autoimmunity of MRL/lpr mice.
    Ito T, Seo N, Yagi H, Ohtani T, Tokura Y, Takigawa M, Furukawa F.
    J Dermatol Sci; 2002 Apr 18; 28(3):198-210. PubMed ID: 11912007
    [Abstract] [Full Text] [Related]

  • 28. Longdan Xiegan Tang has immunomodulatory effects on CD4+CD25+ T cells and attenuates pathological signs in MRL/lpr mice.
    Lee TY, Chang HH.
    Int J Mol Med; 2010 May 18; 25(5):677-85. PubMed ID: 20372809
    [Abstract] [Full Text] [Related]

  • 29. T helper cell subsets in the pathogenesis of systemic lupus erythematosus.
    Reininger L, Santiago ML, Takahashi S, Fossati L, Izui S.
    Ann Med Interne (Paris); 1996 May 18; 147(7):467-71. PubMed ID: 9092356
    [Abstract] [Full Text] [Related]

  • 30. T cell-derived IFN-γ downregulates protective group 2 innate lymphoid cells in murine lupus erythematosus.
    Düster M, Becker M, Gnirck AC, Wunderlich M, Panzer U, Turner JE.
    Eur J Immunol; 2018 Aug 18; 48(8):1364-1375. PubMed ID: 29671873
    [Abstract] [Full Text] [Related]

  • 31. Viral double-stranded RNA aggravates lupus nephritis through Toll-like receptor 3 on glomerular mesangial cells and antigen-presenting cells.
    Patole PS, Gröne HJ, Segerer S, Ciubar R, Belemezova E, Henger A, Kretzler M, Schlöndorff D, Anders HJ.
    J Am Soc Nephrol; 2005 May 18; 16(5):1326-38. PubMed ID: 15772251
    [Abstract] [Full Text] [Related]

  • 32. A pivotal role of cell-bound but not soluble CD4 molecules in full development of lupus-like manifestations in MRL-Fas(lprcg)/Fas(lprcg) mice.
    Zhang Y, Yasuda T, Wang CR, Yoshimoto T, Nagase H, Takamoto M, Tsubura A, Kimura M, Matsuzawa A.
    Clin Exp Immunol; 2000 Oct 18; 122(1):124-32. PubMed ID: 11012628
    [Abstract] [Full Text] [Related]

  • 33. Oral administration of artemisinin analog SM934 ameliorates lupus syndromes in MRL/lpr mice by inhibiting Th1 and Th17 cell responses.
    Hou LF, He SJ, Li X, Yang Y, He PL, Zhou Y, Zhu FH, Yang YF, Li Y, Tang W, Zuo JP.
    Arthritis Rheum; 2011 Aug 18; 63(8):2445-55. PubMed ID: 21484768
    [Abstract] [Full Text] [Related]

  • 34. Inhibition of glutaminolysis ameliorates lupus by regulating T and B cell subsets and downregulating the mTOR/P70S6K/4EBP1 and NLRP3/caspase-1/IL-1β pathways in MRL/lpr mice.
    Zhang X, Wang G, Bi Y, Jiang Z, Wang X.
    Int Immunopharmacol; 2022 Nov 18; 112():109133. PubMed ID: 36113317
    [Abstract] [Full Text] [Related]

  • 35. [Effect of CD40 siRNA on inflammatory response of MRL/Lpr mice].
    Wang ZH, Zhang W, Zhang YQ, Pang CY, Wang YF.
    Beijing Da Xue Xue Bao Yi Xue Ban; 2016 Oct 18; 48(5):771-776. PubMed ID: 27752154
    [Abstract] [Full Text] [Related]

  • 36. Cordyceps protein alleviates renal injury by inhibiting T cell infiltration and Th1 cell differentiation in lupus nephritis mice.
    Liao Z, Yang X, He L, Bai J, Zhou X, Yang J, Niu S, Liu S, Guo J.
    Int Immunopharmacol; 2024 Sep 10; 138():112566. PubMed ID: 38943968
    [Abstract] [Full Text] [Related]

  • 37. Therapeutic effects of the artemisinin analog SM934 on lupus-prone MRL/lpr mice via inhibition of TLR-triggered B-cell activation and plasma cell formation.
    Wu Y, He S, Bai B, Zhang L, Xue L, Lin Z, Yang X, Zhu F, He P, Tang W, Zuo J.
    Cell Mol Immunol; 2016 May 10; 13(3):379-90. PubMed ID: 25942599
    [Abstract] [Full Text] [Related]

  • 38. In vivo cytokine gene expression in various T cell subsets of the autoimmune MRL/Mp-lpr/lpr mouse.
    Mori K, Kobayashi S, Inobe M, Jia WY, Tamakoshi M, Miyazaki T, Uede T.
    Autoimmunity; 1994 May 10; 17(1):49-57. PubMed ID: 7517710
    [Abstract] [Full Text] [Related]

  • 39. Therapeutic targeting of BET protein BRD4 delays murine lupus.
    Wei S, Sun Y, Sha H.
    Int Immunopharmacol; 2015 Dec 10; 29(2):314-319. PubMed ID: 26590112
    [Abstract] [Full Text] [Related]

  • 40. JAK inhibitor has the amelioration effect in lupus-prone mice: the involvement of IFN signature gene downregulation.
    Ikeda K, Hayakawa K, Fujishiro M, Kawasaki M, Hirai T, Tsushima H, Miyashita T, Suzuki S, Morimoto S, Tamura N, Takamori K, Ogawa H, Sekigawa I.
    BMC Immunol; 2017 Aug 22; 18(1):41. PubMed ID: 28830352
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.